English
Please Select Search Type
Please Enter Keywords
Search
Please Select Search Type
Please Enter Keywords
Search
English
Current Location:
Reports
Global Flu Vaccine Market Size, Competition Landscape and Supply Chain Research Report 2026

Global Flu Vaccine Market Size, Competition Landscape and Supply Chain Research Report 2026

Published : 2026-01-25
Pages : 155
Tables and Figures : 170
Report ID : WENKH003673
Report Format :
Delivery : 48-72h
Select Type ：
Full Report
Competitive Landscape
Select Version ：
Single Users License：$ 3700
Buy Now
Request Sample
Custom Reports
Contact Us
Important Clause:
Recently, our company has discovered that some websites have plagiarized, quoted and modified our original report catalog without authorization, and sold reports under our brand, which has seriously infringed our interests. Therefore, our company recommends that you contact the relevant phone number, email address or leave a message to purchase the report to prevent being deceived.
*All report contents displayed on this website are original to WENKH, and our company has the sole copyright. Any modification, reprinting or quoting in any form is prohibited without our prior written permission. Otherwise, our company reserves the right to pursue legal responsibility.
Research Scope
Table of Contents
Tables and Figures
Full Report

Research Summary

The flu vaccine is a preventive immunization designed to protect against influenza by stimulating the human immune system to produce specific antibodies against flu viruses, thereby reducing the risk of infection or mitigating the severity of illness. Because influenza viruses mutate frequently, the vaccine composition is updated annually based on the strains recommended by the World Health Organization (WHO). Common types of flu vaccines include inactivated vaccines, live attenuated vaccines, and recombinant vaccines, tailored for different age groups and health conditions. Vaccination is particularly important for older adults, children, pregnant women, and individuals with chronic diseases or weakened immune systems, as it helps reduce complications, hospitalizations, and mortality. As a key public health measure, flu vaccination is widely promoted worldwide and plays a crucial role in controlling seasonal influenza outbreaks, protecting vulnerable populations, and easing the burden on healthcare systems.

According to WENKH research statistics, the global Flu Vaccine market size will reach 10,457 Million USD in 2026 and is projected to reach 15,322 Million USD by 2033, with a CAGR of 5.61% (2026-2033). Among them, the Asia-Pacific Flu Vaccine market is undergoing rapid changes, reaching Million USD in 2026, accounting for approximately % of the global market share. It is projected to reach Million USD by 2033.

The influenza vaccine market presents a compelling opportunity for new entrants, particularly in regions where immunization coverage remains inconsistent and infrastructure for seasonal vaccination is still developing. In emerging markets across Asia, Africa, and Latin America, rising healthcare awareness, increasing government initiatives, and a growing middle-class population are collectively driving demand for reliable influenza prevention solutions. New players with cost-effective, easy-to-distribute vaccines that meet World Health Organization prequalification standards could quickly gain traction, especially if they offer quadrivalent formulations that provide broader protection.

Another critical opening lies in the innovation of vaccine delivery methods. Traditional intramuscular injections, while effective, are often associated with lower patient compliance. New entrants that explore needle-free technologies, microneedle patches, or thermostable formulations stand to differentiate themselves in both mature and underserved markets. Moreover, as the global healthcare industry continues to pivot toward preventive care, partnerships with local healthcare providers, public health agencies, and non-governmental organizations can offer vital channels for market entry and sustained adoption. Newcomers that align their strategies with national immunization programs and tailor their offerings to meet local logistical and epidemiological realities will likely find a faster route to scale and impact.

The global Flu Vaccine market is highly competitive, with key market players including Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological, SIOBP, GSK, Mylan, CSL, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec, etc. This report categorizes the competitive landscape of the global Flu Vaccine market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Flu Vaccine market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Flu Vaccine industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Flu Vaccine and their downstream application fields.

In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2021 to 2025, providing a solid foundation for analyzing past market trends. The year 2026 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2027 to 2033, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Flu Vaccine in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Flu Vaccine market. By considering local policies, this report evaluates the market prospects of Flu Vaccine in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

Hualan Bio

CCBIO

Aleph Biomedical

SANOFI

Adimmune

ZYAK

SINOVAC

Changsheng Biological

SIOBP

GSK

Mylan

CSL

Aimei Hissen

Tianyuan Bio-pharma(Novartis)

Simcere Vaxtec

Product Segment

Split Influenza Vaccine

Pandemic Influenza Vaccine

Subunit Influenza Vaccine

Quadrivalent Influenza Vaccine

Product Application

For Children (6 months to 3 years)

For Adults and Children over 3 years


Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Flu Vaccine Industry Chain Analysis

Chapter 3: Global Flu Vaccine Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Flu Vaccine Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Flu Vaccine Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America Flu Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe Flu Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China Flu Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) Flu Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America Flu Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa Flu Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source


Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.

Table of Content

1 Flu Vaccine Market Overview

   1.1 Product Definition Introduction

   1.2 Global Flu Vaccine Market Size and Growth Forecast Analysis (2021-2033)

   1.3 Flu Vaccine Market Status and Development Prospects

       1.3.1 Flu Vaccine Market Status

       1.3.2 Flu Vaccine Industry Development Prospects

   1.4 Flu Vaccine Market Overview by Product Segment

       1.4.1 Global Flu Vaccine Market Size and Growth Forecast Analysis by Product Segment: 2021 VS 2026 VS 2033

       1.4.2 Split Influenza Vaccine

       1.4.3 Pandemic Influenza Vaccine

       1.4.4 Subunit Influenza Vaccine

       1.4.5 Quadrivalent Influenza Vaccine

   1.5 Flu Vaccine Market Overview by Product Application

       1.5.1 Global Flu Vaccine Market Size and Growth Forecast Analysis by Product Application: 2021 VS 2026 VS 2033

       1.5.2 For Children (6 months to 3 years)

       1.5.3 For Adults and Children over 3 years

2 Flu Vaccine Industry Supply Chain Analysis

   2.1 Flu Vaccine Supply Chain

   2.2 Flu Vaccine Industry Upstream Supply Analysis

       2.2.1 Upstream Raw Materials Supply Status

       2.2.2 Key Raw Material Suppliers

   2.3 Flu Vaccine Midstream Manufacturers

   2.4 Flu Vaccine Downstream Customers

   2.5 Flu Vaccine Sales Channel Analysis

3 Flu Vaccine Market Environment Analysis

   3.1 Flu Vaccine Industry Policy Analysis

   3.2 Flu Vaccine Emerging Technology Trends in the Industry

   3.3 Flu Vaccine Restraining Factors Analysis

   3.4 Flu Vaccine Market Porter's Five Forces Analysis

       3.4.1 Competitive Rivalry

       3.4.2 Threat of New Entrants

       3.4.3 Bargaining Power of Suppliers

       3.4.4 Bargaining Power of Buyers

       3.4.5 Threat of Substitute Products or Services

4 Global Flu Vaccine Manufacturer Competition Landscape

   4.1 Global Flu Vaccine Market Sales Volume, Revenue by Key Manufacturers (2021-2026)

       4.1.1 Global Flu Vaccine Market Sales Volume by Key Manufacturers (2021-2026)

       4.1.2 Global Flu Vaccine Market Revenue by Key Manufacturers (2021-2026)

   4.2 Global Flu Vaccine Market Position by Key Manufacturers

   4.3 China Flu Vaccine Market Position by Key Manufacturers

   4.4 Global Key Manufacturers Headquarter and Key Area Served

   4.5 Global Flu Vaccine Market Expansion and M&A Dynamic

5 In-depth Analysis of Key Players

   5.1 Hualan Bio

       5.1.1 Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.1.2 Hualan Bio Flu Vaccine Product Features

       5.1.3 Hualan Bio Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.1.4 Hualan Bio Flu Vaccine Revenue by Product Segment

       5.1.5 Hualan Bio Flu Vaccine Revenue by Region

   5.2 CCBIO

       5.2.1 CCBIO Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.2.2 CCBIO Flu Vaccine Product Features

       5.2.3 CCBIO Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.2.4 CCBIO Flu Vaccine Revenue by Product Segment

       5.2.5 CCBIO Flu Vaccine Revenue by Region

   5.3 Aleph Biomedical

       5.3.1 Aleph Biomedical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.3.2 Aleph Biomedical Flu Vaccine Product Features

       5.3.3 Aleph Biomedical Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.3.4 Aleph Biomedical Flu Vaccine Revenue by Product Segment

       5.3.5 Aleph Biomedical Flu Vaccine Revenue by Region

   5.4 SANOFI

       5.4.1 SANOFI Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.4.2 SANOFI Flu Vaccine Product Features

       5.4.3 SANOFI Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.4.4 SANOFI Flu Vaccine Revenue by Product Segment

       5.4.5 SANOFI Flu Vaccine Revenue by Region

   5.5 Adimmune

       5.5.1 Adimmune Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.5.2 Adimmune Flu Vaccine Product Features

       5.5.3 Adimmune Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.5.4 Adimmune Flu Vaccine Revenue by Product Segment

       5.5.5 Adimmune Flu Vaccine Revenue by Region

   5.6 ZYAK

       5.6.1 ZYAK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.6.2 ZYAK Flu Vaccine Product Features

       5.6.3 ZYAK Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.6.4 ZYAK Flu Vaccine Revenue by Product Segment

       5.6.5 ZYAK Flu Vaccine Revenue by Region

   5.7 SINOVAC

       5.7.1 SINOVAC Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.7.2 SINOVAC Flu Vaccine Product Features

       5.7.3 SINOVAC Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.7.4 SINOVAC Flu Vaccine Revenue by Product Segment

       5.7.5 SINOVAC Flu Vaccine Revenue by Region

   5.8 Changsheng Biological

       5.8.1 Changsheng Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.8.2 Changsheng Biological Flu Vaccine Product Features

       5.8.3 Changsheng Biological Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.8.4 Changsheng Biological Flu Vaccine Revenue by Product Segment

       5.8.5 Changsheng Biological Flu Vaccine Revenue by Region

   5.9 SIOBP

       5.9.1 SIOBP Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.9.2 SIOBP Flu Vaccine Product Features

       5.9.3 SIOBP Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.9.4 SIOBP Flu Vaccine Revenue by Product Segment

       5.9.5 SIOBP Flu Vaccine Revenue by Region

   5.10 GSK

       5.10.1 GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.10.2 GSK Flu Vaccine Product Features

       5.10.3 GSK Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.10.4 GSK Flu Vaccine Revenue by Product Segment

       5.10.5 GSK Flu Vaccine Revenue by Region

   5.11 Mylan

       5.11.1 Mylan Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.11.2 Mylan Flu Vaccine Product Features

       5.11.3 Mylan Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.11.4 Mylan Flu Vaccine Revenue by Product Segment

       5.11.5 Mylan Flu Vaccine Revenue by Region

   5.12 CSL

       5.12.1 CSL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.12.2 CSL Flu Vaccine Product Features

       5.12.3 CSL Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.12.4 CSL Flu Vaccine Revenue by Product Segment

       5.12.5 CSL Flu Vaccine Revenue by Region

   5.13 Aimei Hissen

       5.13.1 Aimei Hissen Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.13.2 Aimei Hissen Flu Vaccine Product Features

       5.13.3 Aimei Hissen Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.13.4 Aimei Hissen Flu Vaccine Revenue by Product Segment

       5.13.5 Aimei Hissen Flu Vaccine Revenue by Region

   5.14 Tianyuan Bio-pharma(Novartis)

       5.14.1 Tianyuan Bio-pharma(Novartis) Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.14.2 Tianyuan Bio-pharma(Novartis) Flu Vaccine Product Features

       5.14.3 Tianyuan Bio-pharma(Novartis) Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.14.4 Tianyuan Bio-pharma(Novartis) Flu Vaccine Revenue by Product Segment

       5.14.5 Tianyuan Bio-pharma(Novartis) Flu Vaccine Revenue by Region

   5.15 Simcere Vaxtec

       5.15.1 Simcere Vaxtec Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.15.2 Simcere Vaxtec Flu Vaccine Product Features

       5.15.3 Simcere Vaxtec Flu Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

       5.15.4 Simcere Vaxtec Flu Vaccine Revenue by Product Segment

       5.15.5 Simcere Vaxtec Flu Vaccine Revenue by Region

6 Global Flu Vaccine Market Analysis by Regions, by Product Segment and Application

   6.1 Global Flu Vaccine Market Size and Growth Forecast by Region: 2021 VS 2026 VS 2033

       6.1.1 Global Flu Vaccine Market Revenue by Region (2021-2026)

       6.1.2 Global Flu Vaccine Market Revenue Forecast by Region (2027-2033)

   6.2 Global Flu Vaccine Market Sales Volume Analysis

       6.2.1 Global Flu Vaccine Market Sales Volume by Region (2021-2026)

       6.2.2 Global Flu Vaccine Market Sales Volume Forecast by Region (2027-2033)

   6.3 Global Flu Vaccine Market by Product Segment (2021-2033)

       6.3.1 Global Flu Vaccine Market Revenue and Forecast by Product Segment

       6.3.2 Global Flu Vaccine Market Sales Volume and Forecast by Product Segment

   6.4 Global Flu Vaccine Market by Product Application (2021-2033)

       6.4.1 Global Flu Vaccine Market Revenue and Forecast by Product Application

       6.4.2 Global Flu Vaccine Market Sales Volume and Forecast by Product Application

7 North America Flu Vaccine Market Analysis

   7.1 North America Flu Vaccine Market Prospects

       7.1.1 North America Flu Vaccine Market Revenue and Growth Forecast by Countries (2021-2033)

       7.1.2 North America Flu Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

       7.1.3 U.S.

       7.1.4 Canada

   7.2 North America Flu Vaccine Market by Product Segment (2021-2033)

       7.2.1 North America Flu Vaccine Market Revenue and Forecast Analysis by Product Segment

       7.2.2 North America Flu Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   7.3 North America Flu Vaccine Market by Product Application (2021-2033)

       7.3.1 North America Flu Vaccine Market Revenue and Forecast Analysis by Product Application

       7.3.2 North America Flu Vaccine Market Sales Volume and Forecast Analysis by Product Application

8 Europe Flu Vaccine Market Analysis

   8.1 Europe Flu Vaccine Market Prospects

       8.1.1 Europe Flu Vaccine Market Revenue and Growth Forecast by Countries (2021-2033)

       8.1.2 Europe Flu Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

       8.1.3 Germany

       8.1.4 France

       8.1.5 United Kingdom

       8.1.6 Italy

       8.1.7 Spain

       8.1.8 Benelux

   8.2 Europe Flu Vaccine Market by Product Segment (2021-2033)

       8.2.1 Europe Flu Vaccine Market Revenue and Forecast Analysis by Product Segment

       8.2.2 Europe Flu Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   8.3 Europe Flu Vaccine Market by Product Application (2021-2033)

       8.3.1 Europe Flu Vaccine Market Revenue and Forecast Analysis by Product Application

       8.3.2 Europe Flu Vaccine Market Sales Volume and Forecast Analysis by Product Application

9 China Flu Vaccine Market Analysis

   9.1 China Flu Vaccine Market Prospects

       9.1.1 China Flu Vaccine Revenue and Growth Forecast (2021-2033)

       9.1.2 China Flu Vaccine Market Sales Volume and Growth Forecast (2021-2033)

   9.2 China Flu Vaccine Market by Product Segment (2021-2033)

       9.2.1 China Flu Vaccine Market Revenue and Forecast Analysis by Product Segment

       9.2.2 China Flu Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   9.3 China Flu Vaccine Market by Product Application (2021-2033)

       9.3.1 China Flu Vaccine Market Revenue and Forecast Analysis by Product Application

       9.3.2 China Flu Vaccine Market Sales Volume and Forecast Analysis by Product Application

10 Asia Pacific (excl. China) Flu Vaccine Market Analysis

   10.1 Asia Pacific (excl. China) Flu Vaccine Market Prospects

       10.1.1 Asia Pacific (excl. China) Flu Vaccine Revenue and Growth Forecast by Countries (2021-2033)

       10.1.2 Asia Pacific (excl. China) Flu Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

       10.1.3 Japan

       10.1.4 South Korea

       10.1.5 India

       10.1.6 Southeast Asia

       10.1.7 Australia

   10.2 Asia Pacific (excl. China) Flu Vaccine Market by Product Segment (2021-2033)

       10.2.1 Asia Pacific (excl. China) Flu Vaccine Market Revenue and Forecast Analysis by Product Segment

       10.2.2 Asia Pacific (excl. China) Flu Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   10.3 Asia Pacific (excl. China) Flu Vaccine Market by Product Application (2021-2033)

       10.3.1 Asia Pacific (excl. China) Flu Vaccine Market Revenue and Forecast Analysis by Product Application

       10.3.2 Asia Pacific (excl. China) Flu Vaccine Market Sales Volume and Forecast Analysis by Product Application

11 Latin America Flu Vaccine Market Analysis

   11.1 Latin America Flu Vaccine Market Prospects

       11.1.1 Latin America Flu Vaccine Revenue and Growth Forecast by Countries (2021-2033)

       11.1.2 Latin America Flu Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

       11.1.3 Mexico

       11.1.4 Brazil

   11.2 Latin America Flu Vaccine Market by Product Segment (2021-2033)

       11.2.1 Latin America Flu Vaccine Market Revenue and Forecast Analysis by Product Segment

       11.2.2 Latin America Flu Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   11.3 Latin America Flu Vaccine Market by Product Application (2021-2033)

       11.3.1 Latin America Flu Vaccine Market Revenue and Forecast Analysis by Product Application

       11.3.2 Latin America Flu Vaccine Market Sales Volume and Forecast Analysis by Product Application

12 Middle East and Africa Flu Vaccine Market Analysis

   12.1 Middle East and Africa Flu Vaccine Market Prospects

       12.1.1 Middle East and Africa Flu Vaccine Revenue and Growth Forecast by Countries (2021-2033)

       12.1.2 Middle East and Africa Flu Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

       12.1.3 Saudi Arabia

       12.1.4 South Africa

   12.2 Middle East and Africa Flu Vaccine Market by Product Segment (2021-2033)

       12.2.1 Middle East and Africa Flu Vaccine Market Revenue and Forecast Analysis by Product Segment

       12.2.2 Middle East and Africa Flu Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   12.3 Middle East and Africa Flu Vaccine Market by Product Application (2021-2033)

       12.3.1 Middle East and Africa Flu Vaccine Market Revenue and Forecast Analysis by Product Application

       12.3.2 Middle East and Africa Flu Vaccine Market Sales Volume and Forecast Analysis by Product Application

13 Research Conclusion

14 Appendix

   14.1 Methodology/Research Approach

   14.2 Research Landscape

   14.3 Research Benchmark and Hypothesis

   14.4 Data Source

       14.4.1 Primary Sources

       14.4.2 Secondary Sources

   14.5 Data Cross Validation

   14.6 Disclaimer

image.png

Table 1：Global Flu Vaccine Product Segment Market Size and Growth Forecast Analysis (2021 VS 2026 VS 2033) & (Million USD)

Table 2：Global Flu Vaccine Market Size and Growth Forecast Analysis by Application (2021 VS 2026 VS 2033) & (Million USD)

Table 3：Key Raw Materials and Market Concentration

Table 4：Flu Vaccine Raw Material Suppliers and Contact Information

Table 5：Flu Vaccine Downstream Customers List

Table 6：Flu Vaccine Distributors/Dealers List

Table 7：Global Flu Vaccine Capacity by Countries (2021-2026) & (K Doses)

Table 8：Global Flu Vaccine Production by Countries (2021-2026) & (K Doses)

Table 9：Global Flu Vaccine Market Sales Volume by Key Manufacturers (2021-2026) & (K Doses)

Table 10：Global Flu Vaccine Market Revenue by Key Manufacturers (2021-2026) & (Million USD)

Table 11：Global Flu Vaccine Market Position by Key Manufacturers

Table 12：China Flu Vaccine Market Position by Key Manufacturers

Table 13：Global Key Manufacturers Headquarter and Key Area Served

Table 14：Global Flu Vaccine Market Expansion and M&A Dynamic

Table 15：Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 16：Hualan Bio Flu Vaccine Product Features

Table 17：Hualan Bio Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 18：Hualan Bio Flu Vaccine Revenue by Product Segment

Table 19：Hualan Bio Flu Vaccine Revenue by Region

Table 20：CCBIO Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 21：CCBIO Flu Vaccine Product Features

Table 22：CCBIO Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 23：CCBIO Flu Vaccine Revenue by Product Segment

Table 24：CCBIO Flu Vaccine Revenue by Region

Table 25：Aleph Biomedical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 26：Aleph Biomedical Flu Vaccine Product Features

Table 27：Aleph Biomedical Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 28：Aleph Biomedical Flu Vaccine Revenue by Product Segment

Table 29：Aleph Biomedical Flu Vaccine Revenue by Region

Table 30：SANOFI Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 31：SANOFI Flu Vaccine Product Features

Table 32：SANOFI Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 33：SANOFI Flu Vaccine Revenue by Product Segment

Table 34：SANOFI Flu Vaccine Revenue by Region

Table 35：Adimmune Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 36：Adimmune Flu Vaccine Product Features

Table 37：Adimmune Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 38：Adimmune Flu Vaccine Revenue by Product Segment

Table 39：Adimmune Flu Vaccine Revenue by Region

Table 40：ZYAK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 41：ZYAK Flu Vaccine Product Features

Table 42：ZYAK Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 43：ZYAK Flu Vaccine Revenue by Product Segment

Table 44：ZYAK Flu Vaccine Revenue by Region

Table 45：SINOVAC Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 46：SINOVAC Flu Vaccine Product Features

Table 47：SINOVAC Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 48：SINOVAC Flu Vaccine Revenue by Product Segment

Table 49：SINOVAC Flu Vaccine Revenue by Region

Table 50：Changsheng Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 51：Changsheng Biological Flu Vaccine Product Features

Table 52：Changsheng Biological Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 53：Changsheng Biological Flu Vaccine Revenue by Product Segment

Table 54：Changsheng Biological Flu Vaccine Revenue by Region

Table 55：SIOBP Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 56：SIOBP Flu Vaccine Product Features

Table 57：SIOBP Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 58：SIOBP Flu Vaccine Revenue by Product Segment

Table 59：SIOBP Flu Vaccine Revenue by Region

Table 60：GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 61：GSK Flu Vaccine Product Features

Table 62：GSK Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 63：GSK Flu Vaccine Revenue by Product Segment

Table 64：GSK Flu Vaccine Revenue by Region

Table 65：Mylan Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 66：Mylan Flu Vaccine Product Features

Table 67：Mylan Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 68：Mylan Flu Vaccine Revenue by Product Segment

Table 69：Mylan Flu Vaccine Revenue by Region

Table 70：CSL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 71：CSL Flu Vaccine Product Features

Table 72：CSL Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 73：CSL Flu Vaccine Revenue by Product Segment

Table 74：CSL Flu Vaccine Revenue by Region

Table 75：Aimei Hissen Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 76：Aimei Hissen Flu Vaccine Product Features

Table 77：Aimei Hissen Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 78：Aimei Hissen Flu Vaccine Revenue by Product Segment

Table 79：Aimei Hissen Flu Vaccine Revenue by Region

Table 80：Tianyuan Bio-pharma(Novartis) Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 81：Tianyuan Bio-pharma(Novartis) Flu Vaccine Product Features

Table 82：Tianyuan Bio-pharma(Novartis) Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 83：Tianyuan Bio-pharma(Novartis) Flu Vaccine Revenue by Product Segment

Table 84：Tianyuan Bio-pharma(Novartis) Flu Vaccine Revenue by Region

Table 85：Simcere Vaxtec Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 86：Simcere Vaxtec Flu Vaccine Product Features

Table 87：Simcere Vaxtec Flu Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 88：Simcere Vaxtec Flu Vaccine Revenue by Product Segment

Table 89：Simcere Vaxtec Flu Vaccine Revenue by Region

Table 90：Global Flu Vaccine Market Size and Growth Forecast by Region (2021 VS 2026 VS 2033) & (Million USD)

Table 91：Global Flu Vaccine Market Revenue by Region (2021-2026) & (Million USD)

Table 92：Global Flu Vaccine Market Share by Region (2021-2026)

Table 93：Global Flu Vaccine Market Revenue Forecast by Region (2027-2033) & (Million USD)

Table 94：Global Flu Vaccine Market Share Forecast by Region (2027-2033)

Table 95：Global Flu Vaccine Market Sales by Region (2021-2026) & (K Doses)

Table 96：Global Flu Vaccine Sales Volume Market Share by Region (2021-2026)

Table 97：Global Flu Vaccine Market Sales Volume Forecast by Region (2027-2033) & (K Doses)

Table 98：Global Flu Vaccine Sales Volume Market Share Forecast by Region (2027-2033)

Table 99：Global Flu Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 100：Global Flu Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 101：Global Flu Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 102：Global Flu Vaccine Market Sales Volume Forecast by Product Segment (2027-2033) & (K Doses)

Table 103：Global Flu Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 104：Global Flu Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 105：Global Flu Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 106：Global Flu Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 107：North America Flu Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 108：North AmericaFlu Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 109：North America Flu Vaccine Market Sales Volume by Countries (2021-2026) & K Doses)

Table 110：North America Flu Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 111：North America Flu Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 112：North America Flu Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 113：North America Flu Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 114：North America Flu Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 115：North America Flu Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 116：North America Flu Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 117：North America Flu Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 118：North America Flu Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 119：Europe Flu Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 120：Europe Flu Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 121：Europe Flu Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 122：Europe Flu Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 123：Europe Flu Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 124：Europe Flu Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 125：Europe Flu Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 126：Europe Flu Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 127：Europe Flu Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 128：Europe Flu Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 129：Europe Flu Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 130：Europe Flu Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 131：China Flu Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 132：China Flu Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 133：China Flu Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 134：China Flu Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 135：China Flu Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 136：China Flu Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 137：China Flu Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 138：China Flu Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 139：Asia Pacific (excl. China) Flu Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 140：Asia Pacific (excl. China) Flu Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 141：Asia Pacific (excl. China) Flu Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 142：Asia Pacific (excl. China) Flu Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 143：Asia Pacific (excl. China) Flu Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 144：Asia Pacific (excl. China) Flu Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 145：Asia Pacific (excl. China) Flu Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 146：Asia Pacific (excl. China) Flu Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 147：Asia Pacific (excl. China) Flu Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 148：Asia Pacific (excl. China) Flu Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 149：Asia Pacific (excl. China) Flu Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 150：Asia Pacific (excl. China) Flu Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 151：Latin America Flu Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 152：Latin America Flu Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 153：Latin America Flu Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 154：Latin America Flu Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 155：Latin America Flu Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 156：Latin America Flu Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 157：Latin America Flu Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 158：Latin America Flu Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 159：Latin America Flu Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 160：Latin America Flu Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 161：Latin America Flu Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 162：Latin America Flu Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 163：Middle East and Africa Flu Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 164：Middle East and Africa Flu Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 165：Middle East and Africa Flu Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 166：Middle East and Africa Flu Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 167：Middle East and Africa Flu Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 168：Middle East and Africa Flu Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 169：Middle East and Africa Flu Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 170：Middle East and Africa Flu Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 171：Middle East and Africa Flu Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 172：Middle East and Africa Flu Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 173：Middle East and Africa Flu Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 174：Middle East and Africa Flu Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 175：Secondary Sources


image.png

Figure 1：Flu Vaccine Product Scope

Figure 2：Global Flu Vaccine Market Size and Growth Forecast Analysis (2021-2033) & (Million USD)

Figure 3：Global Flu Vaccine Sales Volume and Growth Forecast Analysis (2021-2033) & (K Doses)

Figure 4：Global Flu Vaccine Product Segment Market Share (2026 & 2033)

Figure 5：Global Flu Vaccine Product Application Market Share (2026 & 2033)

Figure 6：Split Influenza Vaccine Product Scope

Figure 7：Pandemic Influenza Vaccine Product Scope

Figure 8：Subunit Influenza Vaccine Product Scope

Figure 9：Quadrivalent Influenza Vaccine Product Scope

Figure 10：For Children (6 months to 3 years) Product Scope

Figure 11：For Adults and Children over 3 years Product Scope

Figure 12：Flu Vaccine Industrial Chain Framework

Figure 13：Global Flu Vaccine Capacity, Production and Utilization (2021-2033) & (K Doses)

Figure 14：Global Flu Vaccine Market by Geographic Segmentation in 2026

Figure 15：Global Flu Vaccine Market Share by Region (2021 VS 2026)

Figure 16：Global Flu Vaccine Sales Volume Market Share by Region (2021 VS 2026)

Figure 17：North America Flu Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 18：North America Flu Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 19：North America Flu Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 20：U.S. Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 21：U.S. Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 22：Canada Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 23：Canada Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 24：Europe Flu Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 25：Europe Flu Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 26：Europe Flu Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 27：Germany Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 28：Germany Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 29：France Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 30：France Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 31：United Kingdom Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 32：United Kingdom Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 33：Italy Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 34：Italy Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 35：Spain Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 36：Spain Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 37：Benelux Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 38：Benelux Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 39：China Flu Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 40：China Flu Vaccine Market Sales Volume and Growth Forecast (K Doses)

Figure 41：Asia Pacific (excl. China) Flu Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 42：Asia Pacific (excl. China) Flu Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 43：Asia Pacific (excl. China) Flu Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 44：Japan Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 45：Japan Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 46：South Korea Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 47：South Korea Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 48：India Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 49：India Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 50：Southeast Asia Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 51：Southeast Asia Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 52：Australia Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 53：Australia Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 54：Latin America Flu Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 55：Latin America Flu Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 56：Latin America Flu Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 57：Mexico Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 58：Mexico Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 59：Brazil Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 60：Brazil Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 61：Middle East and Africa Flu Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 62：Middle East and Africa Flu Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 63：Middle East and Africa Flu Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 64：Saudi Arabia Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 65：Saudi Arabia Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 66：South Africa Flu Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 67：South Africa Flu Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 68：Research Methodology

Figure 69：Primary Sources

Figure 70：Data Cross Validation

Global Flu Vaccine Revenue and Market Share by Key Players

Revenue (US$ Million)20202021202220232024
Hualan BioXXXXXXXXXX
CCBIOXXXXXXXXXX
Aleph BiomedicalXXXXXXXXXX
SANOFIXXXXXXXXXX
AdimmuneXXXXXXXXXX
ZYAKXXXXXXXXXX
SINOVACXXXXXXXXXX
Changsheng BiologicalXXXXXXXXXX
SIOBPXXXXXXXXXX
GSKXXXXXXXXXX
MylanXXXXXXXXXX
CSLXXXXXXXXXX
Aimei HissenXXXXXXXXXX
Tianyuan Bio-pharma(Novartis)XXXXXXXXXX
Simcere VaxtecXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Global Flu Vaccine Sales Volume and Market Share by Key Players

Sales (K Doses)20202021202220232024
Hualan BioXXXXXXXXXX
CCBIOXXXXXXXXXX
Aleph BiomedicalXXXXXXXXXX
SANOFIXXXXXXXXXX
AdimmuneXXXXXXXXXX
ZYAKXXXXXXXXXX
SINOVACXXXXXXXXXX
Changsheng BiologicalXXXXXXXXXX
SIOBPXXXXXXXXXX
GSKXXXXXXXXXX
MylanXXXXXXXXXX
CSLXXXXXXXXXX
Aimei HissenXXXXXXXXXX
Tianyuan Bio-pharma(Novartis)XXXXXXXXXX
Simcere VaxtecXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Related Reports

Global Healthcare Supply Chain Managements Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Healthcare Supply Chain Managements Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25

Global Hemodialysis and Peritoneal Dialysis Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Hemodialysis and Peritoneal Dialysis Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25

Global Pharmaceutical CDMO Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Pharmaceutical CDMO Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25

Global Full-Service Clinical Research Organization (CRO) Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Full-Service Clinical Research Organization (CRO) Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25
How to Order
Contact
Fill in your contact information, and the company will quickly match the specialist to get in touch with you
You can also directly call our customer service hotline or add customer service WeChat
Samples
One on one business specialist will send the complete version of the sample
If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
Both parties sign a report purchase contract
Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
PDF report (sent online 2-3 working days after payment)
WORD version report (sent online 2-3 working days after payment)
Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
No Relevant Report Found? Please Contact Us
Custom Reports
WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.
About WENKH
Home
Reports
Custom Research
Industry News
About Us
Contact
Contact Us
Ocean Tower, No.145, Hong Kong Road, Wuhan City, Hube Province, China
Copyright © WENKH.com All rights reserved.